Paper176383
Reexpression of the original tumor pattern by a human breast carcinoma cell line (MCF-7) in sponge culture.
Russo J and 3 others. J Natl Cancer Inst, 1976. Cited by 33 papers, by iCite.
Cite this record
ConductScience Library. Reexpression of the original tumor pattern by a human breast carcinoma cell line (MCF-7) in sponge culture. Papers, record 176383. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/176383
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Reexpression of the original tumor pattern by a human breast carcinoma cell line (MCF-7) in sponge culture.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma, Scirrhous | Major topic |
| Breast Neoplasms | Major topic |
| Cells, Cultured | Major topic |
| Cytological Techniques | Major topic |
| Cell Line |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33528293 | Breast Cancer Reconstruction: Design Criteria for a Humanized Microphysiological System. | Tissue Eng Part A | 2021 | https://conductscience.org/library/papers/33528293 | PubMed |
| 30536579 | Rapid Assessment of Mitochondrial Complex I Activity and Metabolic Phenotyping of Breast Cancer Cells by NAD(p)H Cytometry. | Cytometry A | 2019 | https://conductscience.org/library/papers/30536579 | PubMed |
| 29346400 | The mechanisms how heparin affects the tumor cell induced VEGF and chemokine release from platelets to attenuate the early metastatic niche formation. | PLoS One | 2018 | https://conductscience.org/library/papers/29346400 | PubMed |
| 27769050 | Protein phosphatase Mg2+/Mn2+ dependent 1F promotes smoking-induced breast cancer by inactivating phosphorylated-p53-induced signals. | Oncotarget | 2016 | https://conductscience.org/library/papers/27769050 | PubMed |
| 27387743 | Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial. | BMC Cancer | 2016 | https://conductscience.org/library/papers/27387743 | PubMed |
| 26204487 | Down-regulation of α-L-fucosidase 1 expression confers inferior survival for triple-negative breast cancer patients by modulating the glycosylation status of the tumor cell surface. | Oncotarget | 2015 | https://conductscience.org/library/papers/26204487 | PubMed |
| 6985612 | Absence of fibronectin and presence of plasminogen activator in both normal and malignant human mammary epithelial cells in culture. | J Cell Biol | 1980 | https://conductscience.org/library/papers/6985612 | PubMed |
| 3458228 | In vivo-like growth of human tumors in vitro. | Proc Natl Acad Sci U S A | 1986 | https://conductscience.org/library/papers/3458228 | PubMed |
| 270692 | Hormonal effects on intracellular and secreted casein in cultures of mouse mammary epithelial cells on floating collagen membranes. | Proc Natl Acad Sci U S A | 1977 | https://conductscience.org/library/papers/270692 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/176383
GET https://conductscience.org/api/papers/v1/176383/authors